INNOVATIONS SUBMITTED TO THE 2021 CICI FORUM COMPETITION
The Canada-Israel Cardiovascular Innovation Forum held an innovation competition targeting early and mid-stage companies with projects in either cardiovascular devices or digital heart health. A total of 31 applications were received and 9 were selected to present their innovation at the April 25th CICI Forum Virtual Event. See the list of presenters and applicants below or you may download the list of presenting companies (with summaries of the innovations) or a non-exhaustive list of other innovations submitted to the competition (summaries included).
CANADIAN PRESENTERS
​
​Applicant: Stephanie Buryk-Iggers
Company: SPARKED
Innovation: Handheld, non-invasive device for early risk detection of cardiovascular disease
(read summary of innovation)
(view video of presentation)
​
​Applicant: Daniel Gelman
Company: Aufero Medical
Innovation: Device to stabilize contact force during radiofrequency catheter ablation therapy for atrial fibrillation (view summary of innovation)
​
​Applicant: Surath Gomis
Company: Arma Biosciences
Innovation: A handheld device for rapid, continuous remote monitoring of biochemical markers in patients with heart failure (read summary of innovation)
​
Applicant: Ali Tavallaei
Company: Magellan Biomedical Inc.
Innovation: A novel catheter allowing for accurate localized steering and tracking of endoluminal devices
(view summary of innovation)
​
Applicant: Ryan Tennant
Company: No named company
Innovation: A novel re-entry device for angioplasty of coronary and peripheral chronic total occlusions
(read summary of innovation)
ISRAELI PRESENTERS
​
​Applicant: Lihu Avitov
Company: Revamp Medical
Innovation: The Doraya Catheter - a novel temporary intravenous flow regulator
(read summary of innovation)
​
​Applicant: Nitai Hanani
Company: Paragate Medical Ltd.
Innovation: Implantable Peritoneal Ultrafiltration Device (IPUD) for continuous and active fluid decongestion in heart failure patients
(view summary of innovation)
​
​Applicant: Elon Reshef
Company: Invatin Technologies Ltd.
Innovation: A novel continuous stroke prevention device
(read summary of innovation)
​
Applicant: Ariel Weigler
Company: Cuspa Ltd.
Innovation: Transcatheter artificial cusp for repair of valve insufficiency
(read summary of innovation)
CANADIAN APPLICANTS
​
​Applicant: Sachin Davis
Company: Flora Bioworks
Innovation: A non-invasive diagnostic platform for the identification of atherosclerotic cardiovascular disease via metagenomic sequencing of the gut microbiome
(view summary of innovation)
​
​Applicant: Marko Jovic
Company: Cardian Diagnostics
Innovation: Saliva-based non-invasive monitoring for heart failure patients (view summary of innovation)
​
​Applicant: Haman Mamdouhi
Company: Health-Bridge
Innovation: Health-Bridge: eliminating the language barrier in health care (view summary of innovation)
​
ISRAELI APPLICANTS
​
​​Applicant: Doron Adler
Company: Sanolla
Innovation: AI Powered Primary Care Diagnostics Solutions
(view summary of innovation)
​
​Applicant: Arie Huber
Company: PRC Cardio Optic Ltd.
Innovation: An innovative Imaging System For Directing Guidewire Crossing in Arterial Chronic Total Occlusion (“CTO”) and Reducing Contrast Reagent Use in Coronary Angiography (view summary of innovation)
​
Applicant: Jonathan Maron
Company: VenoVision
Innovation: VenoVision Hemodynamic Remote Monitoring Platform (view summary of innovation)
ATTEND THE 2022 CICI FORUM EVENT
On May 15, 2022 at 12 pm EDT (7 pm IDT), the top rated projects from Israel and Canada will present their pitch. Investors interested in cardiovascular innovations are invited to attend the virtual event and to contact the companies of interest after the presentation. There will be breakout rooms for interested parties to connect with the presenters.
​
The Keynote Speaker for the May 15th event is Peter J. Fitzgerald, MD, PhD, Professor Emeritus Medicine & Engineering at Stanford University Medical Center; Co-founder and Managing partner at Triventures.